Omnicell, Inc. (OMCL)
USD 31.61
(1.35%)
USD 31.61
(1.35%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.14 Billion USD | -11.48% |
| 2022 | 1.29 Billion USD | 14.48% |
| 2021 | 1.13 Billion USD | 26.88% |
| 2020 | 892.2 Million USD | -0.54% |
| 2019 | 897.02 Million USD | 13.94% |
| 2018 | 787.3 Million USD | 9.93% |
| 2017 | 716.16 Million USD | 3.4% |
| 2016 | 692.62 Million USD | 42.94% |
| 2015 | 484.55 Million USD | 9.9% |
| 2014 | 440.9 Million USD | 15.85% |
| 2013 | 380.58 Million USD | 21.19% |
| 2012 | 314.02 Million USD | 27.9% |
| 2011 | 245.53 Million USD | 10.4% |
| 2010 | 222.4 Million USD | 4.19% |
| 2009 | 213.45 Million USD | -15.25% |
| 2008 | 251.86 Million USD | 18.2% |
| 2007 | 213.08 Million USD | 37.73% |
| 2006 | 154.71 Million USD | 27.31% |
| 2005 | 121.51 Million USD | -1.95% |
| 2004 | 123.93 Million USD | 21.36% |
| 2003 | 102.12 Million USD | 16.46% |
| 2002 | 87.69 Million USD | 0.91% |
| 2001 | 86.9 Million USD | 29.0% |
| 2000 | 67.36 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 282.42 Million USD | 2.03% |
| 2024 Q1 | 246.15 Million USD | -4.9% |
| 2024 Q2 | 276.78 Million USD | 12.45% |
| 2023 Q1 | 290.62 Million USD | -2.37% |
| 2023 Q3 | 298.66 Million USD | -0.1% |
| 2023 Q4 | 258.84 Million USD | -13.33% |
| 2023 Q2 | 298.97 Million USD | 2.87% |
| 2023 FY | 1.14 Billion USD | -11.48% |
| 2022 Q1 | 318.82 Million USD | 2.51% |
| 2022 Q3 | 348.05 Million USD | 5.03% |
| 2022 Q2 | 331.38 Million USD | 3.94% |
| 2022 Q4 | 297.67 Million USD | -14.48% |
| 2022 FY | 1.29 Billion USD | 14.48% |
| 2021 Q4 | 311.03 Million USD | 4.94% |
| 2021 Q3 | 296.4 Million USD | 8.68% |
| 2021 Q2 | 272.73 Million USD | 8.3% |
| 2021 FY | 1.13 Billion USD | 26.88% |
| 2021 Q1 | 251.84 Million USD | 1.06% |
| 2020 Q3 | 213.69 Million USD | 7.05% |
| 2020 Q2 | 199.62 Million USD | -13.09% |
| 2020 Q1 | 229.68 Million USD | -7.49% |
| 2020 FY | 892.2 Million USD | -0.54% |
| 2020 Q4 | 249.2 Million USD | 16.61% |
| 2019 Q2 | 217.41 Million USD | 7.36% |
| 2019 FY | 897.02 Million USD | 13.94% |
| 2019 Q4 | 248.29 Million USD | 8.52% |
| 2019 Q1 | 202.51 Million USD | -4.36% |
| 2019 Q3 | 228.8 Million USD | 5.24% |
| 2018 Q1 | 182.61 Million USD | -7.74% |
| 2018 Q3 | 204.26 Million USD | 8.27% |
| 2018 Q4 | 211.75 Million USD | 3.66% |
| 2018 FY | 787.3 Million USD | 9.93% |
| 2018 Q2 | 188.67 Million USD | 3.32% |
| 2017 Q3 | 186.78 Million USD | 3.26% |
| 2017 Q1 | 150.55 Million USD | -12.46% |
| 2017 FY | 716.16 Million USD | 3.4% |
| 2017 Q4 | 197.94 Million USD | 5.98% |
| 2017 Q2 | 180.88 Million USD | 20.15% |
| 2016 Q4 | 171.97 Million USD | -2.69% |
| 2016 FY | 692.62 Million USD | 42.94% |
| 2016 Q3 | 176.73 Million USD | 2.22% |
| 2016 Q2 | 172.9 Million USD | 1.11% |
| 2016 Q1 | 171 Million USD | 31.22% |
| 2015 FY | 484.55 Million USD | 9.9% |
| 2015 Q4 | 130.31 Million USD | 4.06% |
| 2015 Q3 | 125.23 Million USD | 11.03% |
| 2015 Q2 | 112.78 Million USD | -2.95% |
| 2015 Q1 | 116.22 Million USD | -4.38% |
| 2014 Q4 | 121.54 Million USD | 8.0% |
| 2014 FY | 440.9 Million USD | 15.85% |
| 2014 Q1 | 101.76 Million USD | -3.77% |
| 2014 Q2 | 105.05 Million USD | 3.23% |
| 2014 Q3 | 112.54 Million USD | 7.13% |
| 2013 Q4 | 105.75 Million USD | 12.45% |
| 2013 Q2 | 93.68 Million USD | 7.55% |
| 2013 Q3 | 94.03 Million USD | 0.38% |
| 2013 Q1 | 87.11 Million USD | -3.39% |
| 2013 FY | 380.58 Million USD | 21.19% |
| 2012 Q1 | 64.14 Million USD | 1.93% |
| 2012 Q2 | 75.38 Million USD | 17.52% |
| 2012 Q3 | 84.33 Million USD | 11.87% |
| 2012 Q4 | 90.16 Million USD | 6.92% |
| 2012 FY | 314.02 Million USD | 27.9% |
| 2011 Q2 | 61 Million USD | 6.73% |
| 2011 Q4 | 62.93 Million USD | -2.34% |
| 2011 FY | 245.53 Million USD | 10.4% |
| 2011 Q1 | 57.16 Million USD | -0.19% |
| 2011 Q3 | 64.43 Million USD | 5.63% |
| 2010 Q3 | 56.28 Million USD | 2.91% |
| 2010 Q2 | 54.69 Million USD | 0.98% |
| 2010 Q1 | 54.16 Million USD | -0.9% |
| 2010 FY | 222.4 Million USD | 4.19% |
| 2010 Q4 | 57.26 Million USD | 1.74% |
| 2009 Q2 | 52.64 Million USD | 0.84% |
| 2009 FY | 213.45 Million USD | -15.25% |
| 2009 Q3 | 53.95 Million USD | 2.5% |
| 2009 Q1 | 52.2 Million USD | -15.87% |
| 2009 Q4 | 54.65 Million USD | 1.29% |
| 2008 Q3 | 64.34 Million USD | 1.53% |
| 2008 Q2 | 63.37 Million USD | 2.07% |
| 2008 Q1 | 62.09 Million USD | 7.15% |
| 2008 Q4 | 62.05 Million USD | -3.56% |
| 2008 FY | 251.86 Million USD | 18.2% |
| 2007 Q3 | 55.15 Million USD | 6.43% |
| 2007 Q2 | 51.82 Million USD | 7.6% |
| 2007 Q1 | 48.16 Million USD | 9.72% |
| 2007 Q4 | 57.94 Million USD | 5.07% |
| 2007 FY | 213.08 Million USD | 37.73% |
| 2006 FY | 154.71 Million USD | 27.31% |
| 2006 Q1 | 33.91 Million USD | 1.29% |
| 2006 Q2 | 35.97 Million USD | 6.07% |
| 2006 Q3 | 40.93 Million USD | 13.78% |
| 2006 Q4 | 43.89 Million USD | 7.24% |
| 2005 Q4 | 33.48 Million USD | 9.1% |
| 2005 FY | 121.51 Million USD | -1.95% |
| 2005 Q3 | 30.68 Million USD | 7.31% |
| 2005 Q1 | 28.75 Million USD | -15.86% |
| 2005 Q2 | 28.59 Million USD | -0.53% |
| 2004 Q2 | 29.2 Million USD | 4.95% |
| 2004 Q1 | 27.82 Million USD | -2.53% |
| 2004 FY | 123.93 Million USD | 21.36% |
| 2004 Q4 | 34.16 Million USD | 4.38% |
| 2004 Q3 | 32.73 Million USD | 12.08% |
| 2003 Q4 | 28.55 Million USD | 8.32% |
| 2003 Q3 | 26.35 Million USD | 4.84% |
| 2003 Q2 | 25.14 Million USD | 13.89% |
| 2003 Q1 | 22.07 Million USD | 14.63% |
| 2003 FY | 102.12 Million USD | 16.46% |
| 2002 Q3 | 19.07 Million USD | -23.53% |
| 2002 Q4 | 19.25 Million USD | 0.96% |
| 2002 Q1 | 24.41 Million USD | 0.1% |
| 2002 Q2 | 24.94 Million USD | 2.14% |
| 2002 FY | 87.69 Million USD | 0.91% |
| 2001 FY | 86.9 Million USD | 29.0% |
| 2001 Q1 | 18.98 Million USD | 0.0% |
| 2001 Q3 | 22.67 Million USD | 8.82% |
| 2001 Q4 | 24.39 Million USD | 7.57% |
| 2001 Q2 | 20.84 Million USD | 9.76% |
| 2000 FY | 67.36 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Augmedix, Inc. | 44.85 Million USD | -2457.378% |
| OneMedNet Corporation | 1.02 Million USD | -112180.221% |
| Minerva Surgical, Inc. | 50.29 Million USD | -2180.813% |
| CareCloud, Inc. | 117.05 Million USD | -879.943% |
| CareCloud, Inc. | 117.05 Million USD | -879.943% |
| HealthEquity, Inc. | 999.58 Million USD | -14.759% |
| iCoreConnect Inc. | 8.15 Million USD | -13972.255% |
| Progyny, Inc. | 1.08 Billion USD | -5.375% |
| Renalytix Plc | 2.28 Million USD | -50014.111% |
| Schrödinger, Inc. | 216.66 Million USD | -429.438% |
| Simulations Plus, Inc. | 70.01 Million USD | -1538.427% |
| SOPHiA GENETICS SA | 62.37 Million USD | -1739.175% |
| BrightSpring Health Services, Inc. Common Stock | 8.82 Billion USD | 87.003% |
| Streamline Health Solutions, Inc. | 22.59 Million USD | -4976.615% |
| Inovalon Holdings, Inc. | 667.52 Million USD | -71.846% |
| Ontrak, Inc. | 12.74 Million USD | -8901.899% |
| Nutex Health, Inc. | 247.64 Million USD | -363.206% |
| GE HealthCare Technologies Inc. | 19.55 Billion USD | 94.133% |
| Sharecare, Inc. | 445.25 Million USD | -157.633% |
| Aclarion, Inc. | 75.4 Thousand USD | -1521187.995% |
| CareMax, Inc. | 751.1 Million USD | -52.724% |
| Bullfrog AI Holdings, Inc. Common Stock | 65 Thousand USD | -1764687.692% |
| Forian Inc. | 20.48 Million USD | -5500.769% |
| Bullfrog AI Holdings, Inc. Warrants | 65 Thousand USD | -1764687.692% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 202.56 Million USD | -466.29% |
| SCWorx Corp. | 3.8 Million USD | -30047.942% |
| Definitive Healthcare Corp. | 251.41 Million USD | -356.262% |
| 10x Genomics, Inc. | 618.72 Million USD | -85.399% |
| Zhongchao Inc. | 19.43 Million USD | -5802.62% |
| Accolade, Inc. | 414.29 Million USD | -176.885% |
| MSP Recovery, Inc. | 7.7 Million USD | -14787.891% |
| R1 RCM Inc. | 2.25 Billion USD | 49.112% |
| Spok Holdings, Inc. | 139.02 Million USD | -725.112% |
| Privia Health Group, Inc. | 1.65 Billion USD | 30.803% |
| EUDA Health Holdings Limited | 3.7 Million USD | -30849.008% |
| TruBridge, Inc. | 339.43 Million USD | -237.947% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 8.82 Billion USD | 87.003% |
| Sharecare, Inc. | 445.25 Million USD | -157.633% |
| Health Catalyst, Inc. | 295.93 Million USD | -287.619% |
| GoodRx Holdings, Inc. | 750.26 Million USD | -52.894% |
| Premier, Inc. | 1.34 Billion USD | 14.799% |
| HealthStream, Inc. | 279.06 Million USD | -311.058% |
| Certara, Inc. | 354.33 Million USD | -223.735% |
| GeneDx Holdings Corp. | 202.56 Million USD | -466.29% |
| Ontrak, Inc. | 12.74 Million USD | -8901.899% |
| SHL Telemedicine Ltd. | 57.07 Million USD | -1909.833% |
| CareCloud, Inc. | 117.05 Million USD | -879.943% |
| EUDA Health Holdings Limited | 3.7 Million USD | -30849.008% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 731.49 Thousand USD | -156717.905% |
| CareMax, Inc. | 751.1 Million USD | -52.724% |
| Healthcare Triangle, Inc. | 33.2 Million USD | -3354.844% |
| National Research Corporation | 148.58 Million USD | -672.05% |
| Aclarion, Inc. | 75.4 Thousand USD | -1521187.995% |
| OptimizeRx Corporation | 71.52 Million USD | -1503.87% |